Search Icon
SideMenu
Home
Reports

Biosimilars Council Press Releases

Reports
  • Reports

2024 U.S. Generic & Biosimilar Medicines Savings Report
  • Reports

Report: 2023 U.S. Generic and Biosimilar Medicines Savings Report
  • Reports

AAM White Paper on Shortages
  • Reports

AAM Voices of Access
  • Reports

Report: 2022 U.S. Generic and Biosimilar Medicines Savings Report
  • Reports

AAM Voices of Access 2022
  • Reports

AAM Code of Business Ethics
  • Reports

Report: 2021 U.S. Generic and Biosimilar Medicines Savings Report
  • Reports

White Paper: Nitrosamines — An Industry Position Paper Based on Risk
  • Reports

2017 Generic Drug Access and Savings Report
  • Reports

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors
  • Reports

Roadmaps for Ensuring Patient Access to Generic and Biosimilar Medicines: Securing Sustainable Markets
Load More